Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model
Viruses · 2023
DOI: 10.3390/v15010179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Inés Pradal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Biotechnology of Dairy Products, Dairy Research Institute, IPLA-CSIC, 33300 Villaviciosa, Spain. Hauptthemen laut MEDLINE: Enterococcus faecium, Vancomycin-Resistant Enterococci, Moths, Bacteriophages. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Plan for Science, Technology and Innovation of the Principality of Asturias 2018–2022, Spanish National Research Council.
Abstract (Originalsprache)
The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) Enterococcus faecium belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new E. faecium-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of Herelleviridae, subfamily Brockvirinae, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It infects a wide range of E. faecium strains of different origins, including VRE strains. Interestingly, it can also infect Enterococcus faecalis strains, even some that are linezolid-resistant. Its capacity to control the growth of a clinical VRE isolate was shown in broth culture and in a Galleria mellonella animal model. The discovery and characterisation of vB_EfaH_163 increases the number of phages that might be used therapeutically against AMR bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Technology and Biotechnology of Dairy Products, Dairy Research Institute, IPLA-CSIC, 33300 Villaviciosa, Spain.
- Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
- Microbiology Laboratory, Hospital el Bierzo, 24404 Ponferrada, Spain.
- Microbiology Laboratory, Hospital Universitario de Cabueñes, 33394 Gijón, Spain.
ORCID-Profile: Inés Pradal, Beatriz Del Rio, Carlos Rodriguez-Lucas, Miguel A Alvarez, Victor Ladero
Förderung
- Plan for Science, Technology and Innovation of the Principality of Asturias 2018–2022
- Spanish National Research Council
Zitieren
APA
Pradal, I., Casado, A., Del Rio, B., Rodriguez-Lucas, C., Fernandez, M., Alvarez, M. A., & Ladero, V. (2023). Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model. Viruses. https://doi.org/10.3390/v15010179
Vancouver
Pradal I, Casado A, Del Rio B, Rodriguez-Lucas C, Fernandez M, Alvarez MA, et al. Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model. Viruses. 2023. doi:10.3390/v15010179
BibTeX
@article{Pradal2023,
author = {Pradal, Inés and Casado, Angel and Del Rio, Beatriz and Rodriguez-Lucas, Carlos and Fernandez, Maria and Alvarez, Miguel A and Ladero, Victor},
title = {Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010179}
}
EUVIMED